MD Medical Group IPJSC (“MD Medical”, "Group" or the "Company"; MOEX: MDMG), a leading Russian private healthcare provider, announces its operating and unaudited financial results for Q2 and H1 2026.

Key financial highlights for Q2 2026:

• Total revenue grew by 25.9% and amounted to RUB 12,975 million due to strong performance in out-patient and in-patient services, including the results from the newly integrated Expert medical centres network, and high demand for deliveries in the hospitals of the Group.

• Like-for-like (LFL) revenue increased by 12.9% year-on-year to RUB 11,636 million.

• Revenue from Moscow hospitals grew by 11.3% year-on-year to RUB 5,186 million, mainly driven by higher income from deliveries and out-patient visits;

• Revenue from regional hospitals rose by 24.4% year-on-year to RUB 3,431 million, largely due to growth in out-patient services and in-patient care in surgery (including robotic-assisted), traumatology, and gynecology, as well as steady demand for deliveries.

• Revenue from out-patient clinics in Moscow and the Moscow region increased by 19.9% year-on-year to RUB 1,164 million thanks to growth in revenue from out-patient and IVF services.

• Revenue from out-patient clinics in other regions increased by 66.4% year-on-year to RUB 3,149 million, mainly due to a doubling of revenue from out-patient visits, including on the back of contributions from newly opened and acquired in 2024-2026 clinics, as well as a significant increase in revenue from IVF procedures.

• The Group's net debt as of 30.06.2026 amounted to RUB  6,261 million, including RUB 3,706 million in lease obligations[1].

• In Q2 2026, total Capex was RUB 952 million.

Key operational highlights for Q2 2026:

• Total out-patient treatments increased by 47.3% y-o-y to 1,390,197, with the average ticket up 12.5% y-o-y to RUB 7.6 thousand in Moscow and up 11.5% y-o-y to RUB 2.9 thousand in other regions.

• Total in-patient treatments increased by 3.1% y-o-y to 37,256, the number of surgeries grew 22.1%. Average in-patient care ticket was up 5.5% y-o-y to RUB 134.7 thousand in Moscow and up 10.4% y-o-y to RUB 55.2 thousand in other regions.

• Total deliveries increased by 10.9% y-o-y to 3,507, with the average ticket up 4.6% y-o-y to RUB 664.1 thousand in Moscow and up 15.5% y-o-y to RUB 296.1 thousand in other regions.

• Total IVF punctures increased by 3.4% y-o-y to 5,895, with the average ticket up 11.9% to RUB 350.8 thousand in Moscow and up 10.5% y-o-y to RUB 340.1 thousand in other regions.

Key financial highlights for H1 2026:

• Total revenue increased by 28.8% year-on-year to RUB 24,809 million, mainly due to revenue growth from out-patient visits and deliveries.

• Like-for-like (LFL) revenue grew by 11.2% year-on-year to RUB 21,416 million.

• Revenue from Moscow hospitals grew by 10.4% year-on-year to RUB 10,036 million due to increased revenue from deliveries and out-patient services;

• Revenue from regional hospitals increased by 27.2% year-on-year to RUB 6,546 million  on the back of the growth in revenue from out-patient visits and in-patient treatment, as well as the traditional demand for deliveries.

• Revenue from out-patient clinics in Moscow and the Moscow region rose by 18.3% year-on-year to RUB 2,192 million due to the growth in both out-patient visits and IVF procedures.

• Revenue from out-patient clinics in other regions grew by 90.7% year-on-year to RUB 5,946 million, mainly thanks to the results of the newly acquired "Expert" clinics in terms of out-patient visit dynamics, as well as new clinics opened in 2024-2026.

• In H1 2026, total Capex was RUB 2,577 million.

Key operational highlights for H1 2026:

• Total out-patient treatments increased by 71.2% y-o-y to 2,692,178, with the average ticket up 11.8% y-o-y to RUB 7.6 thousand in Moscow and up 9.5% y-o-y to RUB 2.9 thousand in other regions.

• Total in-patient treatments decreased by 0.7% y-o-y to 72,092, the number of surgeries grew 28.6%. Average in-patient care ticket was up 5% y-o-y to RUB 131 thousand in Moscow and up 13.2% y-o-y to RUB 55.4 thousand in other regions.

• Total deliveries increased by 12.5% y-o-y to 6,701, with the average ticket up 5.6% y-o-y to RUB 663.3 thousand in Moscow and up 18.2% y-o-y to RUB 293.6 thousand in other regions.

• Total IVF punctures increased by 0.9% y-o-y to 10,594, with the average ticket up 14.2% to RUB 369.2 thousand in Moscow and up 10.3% y-o-y to RUB 338.3 thousand in other regions.

Key events during Q2 2026 and after the reporting period:

Expansion of the clinic in Moscow. On 8 July 2026 one of the first clinics of the Group, Mother&Child Ugo-Zapad multifunctional family center has now moved to a spacious several-storey building covering an area of 1,077 sq m, which is 276 sq. m. more than the previously occupied premises. The clinic's capacity allows for 78,000 patient appointments per year, which is 12,000 more than the previous capacity, and 1,600 IVF punctures per year. Investments in the clinic expansion amounted to RUB 162 mln.

Holding the Annual General Meeting of Shareholders. On 25 June 2026, at the Company's Annual General Meeting of Shareholders, in addition to adopting other resolutions, the annual report and annual financial (accounting) statements for 2025 were approved, and a decision was made to distribute part of the Company’s net profit for the 2025 financial year in the amount of RUB 3,530,875,470 as dividend payments.

Acquisition of Ilyinskaya Hospital. On 24 June 2026, MD Medical Group announced the acquisition of Ilyinskaya Hospital, a large multidisciplinary facility in Moscow Region with a total area of 14,088 sq m, opened in 2019. The acquisition price is RUB 8.5 billion, including RUB 1.1 billion of debt on the acquired asset's balance sheet. Payment is made using a combination of the Company’s own and borrowed funds.

Acquisition of out-patient network in Novosibirsk. On 17 June 2026, MD Medical Group announced the acquisition of Zdravitsa, the leading out-patient network in Novosibirsk that covers six out-patient centres with a total area of 4,200 sq m. The clinics can handle 525,000 out-patient appointments per year. The fixed transaction amount is RUB 900 million, to be paid with the Company’s own cash resources.

Expansion of the clinic in Tula. On 1 April 2026 the total area of the Mother and Child Clinic in Tula, which specializes in a wide range of medical services for women's health, including pregnancy management and IVF, increased by 95 square meters and now covers the total area of 636 square meters. The updated clinic will increase the patient flow and capacity of the Group's popular clinic from 24,000 visits to 42,000 visits per year. Investments in the clinic expansion amounted to RUB 18.5 mln.

MD Medical CEO Mark Kurtser said:

“We showed solid growth in the first half of this year: revenue increased by 29%. Out-patient services made an important contribution to this trend: expanding the network and improving access to services allowed us to significantly increase patient flow. Maternity care and IVF remain traditionally strong areas — here we not only maintain high standards of quality but consistently increase the volume of care. Our in-patient capacities also made a significant contribution to revenue growth in Q2: performing complex surgical procedures, including with the help of robotic systems, is a highly demanded skill, and demand remains stable regardless of market conditions.

The reporting period was full of strategically important corporate events. We successfully closed two deals: we acquired a network of out-patient clinics in Novosibirsk and a large hospital in the Moscow region, becoming the largest private bed capacity in the country. These assets strengthen our business model through synergy: we combine advanced protocols, unified quality standards, and top medical staff to provide patients with a seamless treatment journey. Even now, we see opportunities to optimize operational processes and increase resource efficiency.

An important signal for our shareholders was the decision to approve dividends for 2025. This is not just recognition of our financial results, but also a confirmation of our commitment to transparency and fair profit distribution, principles we will continue to follow while maintaining regular dividend payments.

Ahead of us are new challenges and opportunities. We will keep strengthening our industry leadership, developing infrastructure, and implementing innovations to remain a reliable choice for patients and an attractive asset for investors”.

---

[1] Recognised as debt under IFRS 16

***

Notes:
1.     Data is based on management accounts
2.     Minor variations in calculation of totals, subtotals and/or percentage change are due to rounding of decimals



About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. Today, the Company manages 97 state-of-the-art healthcare facilities, including 15 multidisciplinary hospitals and 82 out-patient clinics in 35 regions of the Russian Federation. In 2025, MD Medical Group's revenue amounted to RUB 43.5 bln. while EBITDA stood at RUB 13.3 bln. The Company's ordinary shares are traded on Moscow Exchange (MOEX: MDMG).